Search

everythinglearnresearchcommunity

for

Search:↓

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Tangent screens help detect visual field defects from vigabatrin.

The patient showed tumor stability and improved health using a new Periwinkle preparation with chemotherapy.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Terbinafine is more effective than itraconazole for toenail fungus, especially in older patients, and debridement improves its effectiveness.

Low-dose naltrexone and platelet-rich plasma can regrow hair in lichen planopilaris.

Nilotinib may cause gray hair to return to its original color.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

Certain plant compounds can help prevent and treat a virus in pigs.

Certain alkaloids could help create new coronavirus drugs.

Stopping nalfurafine reversed hair loss in a hemodialysis patient.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Agomelatine might help reduce hair loss caused by valproate.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Low-dose Ritlecitinib may help children with stubborn Alopecia Areata.

RALF22 is essential for root hair growth in response to fungal emissions in Arabidopsis.

The scalp lotion helped increase hair thickness in cancer patients undergoing chemotherapy.

Verteporfin may improve hair regrowth and reduce scarring after hair transplants.

Lamivudine might reverse hair graying and needs more research for potential treatments.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.